Stocks · Health care · Pharmaceutical Preparations

Fulcrum Therapeutics, Inc.

FULC Clue Score33
United States Fiscal year ends December CIK 0001680581 Results filed 27 Apr 2026

What the insiders did No buying or selling

By person

6 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Kevin Tang
10% owner
—
—
—
7,080,945
$24.92M
+6.3%
Ra Capital Management, L.p. entity
10% owner
—
—
—
6,053,960
$21.31M
−40.8%
Robert J Gould
Director
—
—
—
454,864
$1.60M
−9.0%
Greg Tourangeau
Principal Accounting Officer
—
—
—
14,062
$49.50K
−3.4%
Alan Ezekowitz
Director
—
—
—
10,927
$38.46K
−62.2%
Curtis Gale Oltmans
Chief Legal Officer
—
—
—
10,252
$36.09K
−25.2%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.